These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 26551480

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Subconjunctival hemorrhage in a patient on dabigatran (Pradaxa).
    Nguyen TM, Phelan MP, Werdich XQ, Rychwalski PJ, Huff CM.
    Am J Emerg Med; 2013 Feb; 31(2):455.e3-5. PubMed ID: 23000334
    [No Abstract] [Full Text] [Related]

  • 3. [Nosebleed in new oral anticoagulant treatment - what should be done?].
    Stiefelhagen P.
    MMW Fortschr Med; 2015 Sep 10; 157(15):25. PubMed ID: 26349711
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dabigatran levels in omeprazole versus pantoprazole-treated patients with atrial fibrillation: is there a difference?
    Bolek T, Samoš M, Škorňová I, Schnierer M, Lipták P, Bánovčin P, Urban L, Staško J, Kubisz P, Galajda P, Mokán M.
    Eur J Clin Pharmacol; 2019 Jun 10; 75(6):875-877. PubMed ID: 30747244
    [No Abstract] [Full Text] [Related]

  • 9. New anticoagulant drugs among elderly patients is caution necessary?: Comment on "The use of dabigatran in elderly patients".
    Jacobs JM, Stessman J.
    Arch Intern Med; 2011 Jul 25; 171(14):1287-8. PubMed ID: 21788546
    [No Abstract] [Full Text] [Related]

  • 10. Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers.
    Gordon LA, Kumar P, Brooks KM, Kellogg A, McManus M, Alfaro RM, Nghiem K, George JM, Lozier J, Penzak SR, Hadigan C.
    Circulation; 2016 Dec 06; 134(23):1909-1911. PubMed ID: 27920076
    [No Abstract] [Full Text] [Related]

  • 11. [Serious bleeding as a consequence of accumulation of dabigatran caused by renal failure].
    Skjødt-Jensen AM, Hvas AM.
    Ugeskr Laeger; 2014 Jun 09; 176(24):. PubMed ID: 25352200
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dabigatran-induced asymptomatic esophageal mucosal injury.
    Shibagaki K, Taniguchi H, Goto D, Kobayashi K, Kinoshita Y.
    Gastrointest Endosc; 2016 Feb 09; 83(2):472-3; discussion 474. PubMed ID: 26299528
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation].
    Saliba L, Mondoly P, Duparc A, Bura-Rivière A, Maury P, Calmels V, Sallerin B, Pathak A, Montastruc JL, Bagheri H.
    Therapie; 2015 Feb 09; 70(6):485-92. PubMed ID: 26223162
    [Abstract] [Full Text] [Related]

  • 16. Gastrointestinal bleeding under dabigatran.
    Stöllberger C, Lindner K, Finsterer J.
    J Postgrad Med; 2014 Feb 09; 60(2):192-3. PubMed ID: 24823522
    [Abstract] [Full Text] [Related]

  • 17. Depressive symptoms associated with dabigatran: a case report.
    Eryilmaz G, Enez Darcin A, Saglam E, Gogcegoz Gul I.
    Psychogeriatrics; 2015 Sep 09; 15(3):209-11. PubMed ID: 25515766
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Late rebound of dabigatran levels after idarucizumab reversal in two patients with severe renal failure.
    Stecher A, Vene N, Mavri A, Mijovski MB, Krevel B, Gradišek P.
    Eur J Anaesthesiol; 2017 Jun 09; 34(6):400-402. PubMed ID: 28459790
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.